CF-301-102 Study
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
ContraFect Corporation
Start Date
October 14, 2016
End Date
April 30, 2020
Administered By
Duke Clinical Research Institute
Awarded By
ContraFect Corporation
Start Date
October 14, 2016
End Date
April 30, 2020